Conference item icon

Conference item

Lifetime cost-effectiveness simulation of exenatide once-weekly in type 2 diabetes: evidence from the EXSCEL trial

Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1007/s00125-018-4693-0

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Sub department:
Population Health
Role:
Author
ORCID:
0000-0003-1175-3932
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Nuffield Dept of Population Health
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Nuffield Dept of Population Health
Sub department:
Population Health
Role:
Author
Expand authors...
Publisher:
Springer Verlag Publisher's website
Journal:
Diabetologia Journal website
Volume:
61
Issue:
Supplement 1
Pages:
S366
Series:
54th EASD Annual Meeting of the European Association for the Study of Diabetes, Berlin, Germany, 1 – 5 October 2018
Host title:
Diabetologia
Publication date:
2018-08-21
Acceptance date:
2018-06-12
DOI:
EISSN:
1432-0428
ISSN:
0012-186X
Source identifiers:
920842
Pubs id:
pubs:920842
UUID:
uuid:44d49889-da85-47f0-8620-e3cbf3f9a048
Local pid:
pubs:920842
Deposit date:
2018-10-29

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP